AzTrials
AzTrials

Colostomy StomaNCT03108105

Multicenter Study to Describe the Performance of the AOS-C2001-B Device in Patients With Colostomy

A study testing AOS-C2001-B in people with Colostomy Stoma, run by BBraun Medical SAS at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The study evaluates the efficacy of a new 2-piece appliance in patients with colostomy. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Colostomy Stoma
What is being tested?
AOS-C2001-B
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteFrance
Study dates
1 Jun 2017to 7 Nov 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patient is at least 18 years old
  • Patient having a colostomy with a diameter less than 30 mm for users of Ø 55 mm pouches or having a colostomy with a diameter less than 40 mm for users of Ø 65 mm pouches
  • Patient having a colostomy for at least 1 month
  • Patient using a flat ostomy appliance
  • Patient having a stoma protusion smaller than or equal to 1.5 cm
  • Patient capable to apply and remove the appliance himself or with the help of a caregiver (except health care professional)
Show all 9Show fewer
  • Patient having a mental capacity to participate to the study (i.e. to understand the study and to answer to the questions)
  • Patient agreeing to test the new appliance during the evaluation phase (14±3 days)
  • Patient covered by social security

Who cannot join

  • Patient experiencing repeated leakages with the usual pouching system
  • Patient currently suffering from peristomal skin complications (bleeding or red and broken skin at the time of inclusion)
  • Patient receiving or having received, within the last month, chemotherapy, radiotherapy or corticotherapy
  • Patient already participating in another clinical study or who have previously participated in this investigation
  • Pregnant or breast-feeding woman

Trial locations and contacts

1 site in 1 country.

France1 site
  • Elie CHOUILLARD

    Poissy, 78100

Other trials in France

About this study

Official title: Multicenter Pilot Study to Describe the Performance of the AOS-C2001-B Device in Patients With Colostomy

The study evaluates the efficacy of a new 2-piece appliance in patients with colostomy.

Conditions
Colostomy Stoma
Being tested
AOS-C2001-B

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • AOS-C2001-BDevice

    A new 2-piece appliance composed with 2 parts: a base plate and an ostomy collection special pouch (1 base plate for 2 or 3 days and 1 to 4 collection special pouch per day)

Study groups in NCT03108105
Study groupRoleWhat they receive
AOS-C2001-BExperimentalA new 2-piece appliance composed with 2 parts: a base plate and an ostomy collection special pouch (1 base plate for 2 or 3 days and 1 to 4 collection special pouch per day)
Receives: Device: AOS-C2001-B

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Description of efficacy in terms of stool collection and leakage prevention

    After each change of the investigational product, the patient will describe on a 4-point scale the type of capsule cap cover removal

    Measured: At least 1 time per day during 14±3 days

  2. Description of efficacy in terms of stool collection and leakage prevention

    After each change of the investigational product, the patient will describe on a 4-point scale the level of leakage

    Measured: At least 1 time per day during 14±3 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Apr 2017
  2. Study start1 Jun 2017
  3. Primary completion7 Nov 2017
  4. Study completion7 Nov 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03108105
Sponsor's protocol ID
OPM-G-H-1604
Status last verified
Apr 2018
First submitted
5 Apr 2017
Last updated
24 Apr 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing AOS-C2001-B in people with Colostomy Stoma, run by BBraun Medical SAS at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Apr 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Description of efficacy in terms of stool collection and leakage prevention (time frame: At least 1 time per day during 14±3 days). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Apr 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in